YDES
YD Bio Ltd
5.90$
-4.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | LTM* |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | -111.5% | – | -93.1% | -962.2% | – | – | |
| – | – | – | -100.0% | – | – | -100.0% | – | |
| – | 0.0% | – | -102.0% | – | +4,225.8% | -92.3% | – | |
| – | – | – | – | – | – | -92.1% | – | |
| – | +18.8% | -423.5% | – | +576.9% | -2,406.5% | -96.3% | – | |
| – | – | +13,600.0% | -212.6% | – | -199.6% | – | – | |
| – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.